Expedited Analysis and Reporting of Multiple Mutations that Modify Medical Management of Myeloid Malignancies: It's About (Turnaround) Time!

Michael J Kluk; Adam Bagg

doi:10.1016/j.jmoldx.2018.09.001

Expedited Analysis and Reporting of Multiple Mutations that Modify Medical Management of Myeloid Malignancies: It's About (Turnaround) Time!

J Mol Diagn. 2019 Jan;21(1):13-15. doi: 10.1016/j.jmoldx.2018.09.001. Epub 2018 Oct 19.

Authors

Michael J Kluk¹, Adam Bagg²

Affiliations

¹ Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York Presbyterian Hospital, New York, New York.
² Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. Electronic address: [email protected].

PMID: 30347269
DOI: 10.1016/j.jmoldx.2018.09.001

Abstract

This commentary highlights the article by Patel et al that reports a novel custom next-generation sequencing platform for fast detection of select genes in hematologic malignancies.

Publication types

Comment

MeSH terms

Genomics
Hematologic Neoplasms*
High-Throughput Nucleotide Sequencing
Humans
Mutation
Myeloproliferative Disorders*